|
1
|
Yanagisawa M, Kurihara H, Kimura S, et al:
A novel potent vasoconstrictor peptide produced by vascular
endothelial cells. Nature. 332:411–415. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kedzierski RM and Yanagisawa M: Endothelin
system: the double-edged sword in health and disease. Annu Rev
Pharmacol Toxicol. 41:851–876. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rubanyi GM and Polokoff MA: Endothelins:
molecular biology, biochemistry, pharmacology, physiology, and
pathophysiology. Pharmacol Rev. 46:325–415. 1994.PubMed/NCBI
|
|
4
|
Grimshaw MJ: Endothelins in breast tumour
cell invasion. Cancer Lett. 222:129–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Asham E, Shankar A, Loizidou M, et al:
Increased endothelin-1 in colorectal cancer and reduction of tumour
growth by ETA receptor antagonism. Br J Cancer.
85:1759–1763. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eberle J, Fecker LF, Orfanos CE and Geilen
CC: Endothelin-1 decreases basic apoptotic rates in human melanoma
cell lines. J Invest Dermatol. 119:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Douglas ML, Richardson MM and Nicol DL:
Endothelin axis expression is markedly different in the two main
subtypes of renal cell carcinoma. Cancer. 100:2118–2124. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim TH, Xiong H, Zhang Z and Ren B:
β-Catenin activates the growth factor endothelin-1 in colon cancer
cells. Oncogene. 24:597–604. 2005. View Article : Google Scholar
|
|
9
|
Abdel-Gawad IA, Hassanein HM, Bahgat NA,
et al: Study of endothelin-1 and vascular endothelial growth factor
in patients with cancer colon. J Egypt Natl Canc Inst. 20:216–223.
2008.PubMed/NCBI
|
|
10
|
Said N, Smith S, Sanchez-Carbayo M and
Theodorescu D: Tumor endothelin-1 enhances metastatic colonization
of the lung in mouse xenograft models of bladder cancer. J Clin
Invest. 121:132–147. 2011. View
Article : Google Scholar :
|
|
11
|
Nelson JB, Udan MS, Guruli G and Pflug BR:
Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia.
7:631–637. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosano L, Spinella F and Bagnato A:
Endothelin 1 in cancer: biological implications and therapeutic
opportunities. Nat Rev Cancer. 13:637–651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nelson JB, Lee WH, Nguyen SH, et al:
Methylation of the 5′ CpG island of the endothelin B receptor gene
is common in human prostate cancer. Cancer Res. 57:35–37.
1997.PubMed/NCBI
|
|
14
|
Pao MM, Tsutsumi M, Liang G, Uzvolgyi E,
Gonzales FA and Jones PA: The endothelin receptor B (EDNRB)
promoter displays heterogeneous, site specific methylation patterns
in normal and tumor cells. Hum Mol Genet. 10:903–910. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cohen AJ, Belinsky S, Franklin W and Beard
S: Molecular and physiologic evidence for 5′CpG island methylation
of the endothelin B receptor gene in lung cancer. Chest.
121:27S–28S. 2002. View Article : Google Scholar
|
|
16
|
Lo KW, Tsang YS, Kwong J, To KF, Teo PM
and Huang DP: Promoter hypermethylation of the EDNRB gene in
nasopharyngeal carcinoma. Int J Cancer. 98:651–655. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao BJ, Sun DG, Zhang M, Tan SN and Ma X:
Identification of aberrant promoter methylation of EDNRB gene in
esophageal squamous cell carcinoma. Dis Esophagus. 22:55–61. 2009.
View Article : Google Scholar
|
|
18
|
Mathieu MN and Chevillard C: Endothelin-1
and ETA receptor subtype are expressed in the gastric HGT-1 cell
line. J Cardiovasc Pharmacol. 26(Suppl 3): S508–S509. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferrari-Bravo A, Franciosi C, Lissoni P,
Fumagalli L and Uggeri F: Effects of oncological surgery on
endothelin-1 secretion in patients with operable gastric cancer.
Int J Biol Markers. 15:56–57. 2000.PubMed/NCBI
|
|
20
|
Stow LR, Jacobs ME, Wingo CS and Cain BD:
Endothelin-1 gene regulation. FASEB J. 25:16–28. 2011. View Article : Google Scholar :
|
|
21
|
Pan HW, Li SC and Tsai KW: MicroRNA
dysregulation in gastric cancer. Curr Pharm Des. 19:1273–1284.
2013.
|
|
22
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jacobs ME, Wingo CS and Cain BD: An
emerging role for microRNA in the regulation of endothelin-1. Front
Physiol. 4:222013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeligar S, Tsukamoto H and Kalra VK:
Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal
endothelial cells and human endothelial cells involves
hypoxia-inducible factor-1α and microRNA-199. J Immunol.
183:5232–5243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li D, Yang P, Xiong Q, et al:
MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular
endothelial cells. J Hypertens. 28:1646–1654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li D, Yang P, Li H, et al: MicroRNA-1
inhibits proliferation of hepatocarcinoma cells by targeting
endothelin-1. Life Sci. 91:440–447. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li D, He B, Zhang H, et al: The inhibitory
effect of miRNA-1 on ET-1 gene expression. FEBS Lett.
586:1014–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feng B, Cao Y, Chen S, Ruiz M and
Chakrabarti S: miRNA-1 regulates endothelin-1 in diabetes. Life
Sci. 98:18–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen WS, Leung CM, Pan HW, et al:
Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA
hypermethylation in colorectal cancer. Oncol Rep. 28:1069–1076.
2012.PubMed/NCBI
|
|
30
|
Teng XJ, Shen ZX, Xiang JJ, et al: Pre-
and post-operative plasma big endothelin-1 levels in patients with
gastric carcinoma undergoing radical gastrectomy. Anticancer Res.
26:2503–2507. 2006.PubMed/NCBI
|
|
31
|
Whyteside AR, Hinsley EE, Lambert LA,
McDermott PJ and Turner AJ: ECE-1 influences prostate cancer cell
invasion via ET-1-mediated FAK phosphorylation and ET-1-independent
mechanisms. Can J Physiol Pharmacol. 88:850–854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smollich M, Götte M, Yip GW, et al: On the
role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in
human breast cancer. Breast Cancer Res Treat. 106:361–369. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dawson LA, Maitland NJ, Berry P, Turner AJ
and Usmani BA: Expression and localization of endothelin-converting
enzyme-1 in human prostate cancer. Exp Biol Med. 231:1106–1110.
2006.
|
|
34
|
Awano S, Dawson LA, Hunter AR, Turner AJ
and Usmani BA: Endothelin system in oral squamous carcinoma cells:
specific siRNA targeting of ECE-1 blocks cell proliferation. Int J
Cancer. 118:1645–1652. 2006. View Article : Google Scholar
|
|
35
|
Van Beneden R, Michel L, Havaux X, Delos M
and Donckier J: Increased expression of endothelin-1 converting
enzyme in human thyroid carcinoma. Clin Endocrinol. 60:146–147.
2004. View Article : Google Scholar
|
|
36
|
Wiesmann F, Veeck J, Galm O, et al:
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic
inactivation in human breast cancer. Breast Cancer Res. 11:R342009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang R, Lohr CV, Fischer K, et al:
Epigenetic inactivation of endothelin-2 and endothelin-3 in colon
cancer. Int J Cancer. 132:1004–1012. 2013. View Article : Google Scholar
|
|
38
|
Lim JY, Yoon SO, Seol SY, et al:
Overexpression of miR-196b and HOXA10 characterize a poor-prognosis
gastric cancer subtype. World J Gastroenterol. 19:7078–7088. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma J, Liu J, Wang Z, et al:
NF-kappaB-dependent microRNA-425 upregulation promotes gastric
cancer cell growth by targeting PTEN upon IL-1β induction. Mol
Cancer. 13:402014. View Article : Google Scholar
|
|
40
|
Peng WZ, Ma R, Wang F, Yu J and Liu ZB:
Role of miR-191/425 cluster in tumorigenesis and diagnosis of
gastric cancer. Int J Mol Sci. 15:4031–4048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yoshino H, Chiyomaru T, Enokida H, et al:
The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu CD, Kuo YS, Wu HC and Lin CT:
MicroRNA-1 induces apoptosis by targeting prothymosin alpha in
nasopharyngeal carcinoma cells. J Biomed Sci. 18:802011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang F, Song G, Liu M, Li X and Tang H:
miRNA-1 targets fibronectin1 and suppresses the migration and
invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS
Lett. 585:3263–3269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nohata N, Sone Y, Hanazawa T, et al: miR-1
as a tumor suppressive microRNA targeting TAGLN2 in head and neck
squamous cell carcinoma. Oncotarget. 2:29–42. 2011.PubMed/NCBI
|
|
45
|
Nasser MW, Datta J, Nuovo G, et al:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kinoshita T, Nohata N, Fuse M, et al:
Tumor suppressive microRNA-133a regulates novel targets: moesin
contributes to cancer cell proliferation and invasion in head and
neck squamous cell carcinoma. Biochem Biophys Res Commun.
418:378–383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hudson RS, Yi M, Esposito D, et al:
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in
human prostate cancer. Nucleic Acids Res. 40:3689–3703. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Datta J, Kutay H, Nasser MW, et al:
Methylation mediated silencing of microRNA-1 gene and its role in
hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Migliore C, Martin V, Leoni VP, et al:
MiR-1 downregulation cooperates with MACC1 in promoting MET
overexpression in human colon cancer. Clin Cancer Res. 18:737–747.
2012. View Article : Google Scholar
|
|
50
|
Suzuki H, Takatsuka S, Akashi H, et al:
Genome-wide profiling of chromatin signatures reveals epigenetic
regulation of microRNA genes in colorectal cancer. Cancer Res.
71:5646–5658. 2011. View Article : Google Scholar : PubMed/NCBI
|
